Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Gabriella F. Kocsis"'
Autor:
Márton Pipicz, Gabriella F. Kocsis, László Sárváry-Arantes, Péter Bencsik, Zoltán V. Varga, Péter Ferdinandy, Tamás Csont
Publikováno v:
Molecules, Vol 22, Iss 3, p 433 (2017)
Administration of low-dose endotoxin (lipopolysaccharide, LPS) 24 h before a lethal ischemia induces pharmacological late preconditioning. The exact mechanism of this phenomenon is not clear. Here we aimed to investigate whether low-dose LPS exerts l
Externí odkaz:
https://doaj.org/article/c5098fd7b9384846a1604de79c0a533e
Autor:
Márton Pipicz, Gabriella F. Kocsis, Zoltán Varga, Renáta Gáspár, Tamás Csont, Krisztina Kupai, Csaba Csonka
Publikováno v:
British Journal of Pharmacology. 172:3472-3483
Background and Purpose Rapid ventricular pacing (RVP) applied before an index ischaemia has anti-ischaemic effects. Here, we investigated whether RVP applied after index ischaemia attenuates reperfusion injury and whether peroxynitrite, reperfusion i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6068658fead4193ec6fb657e90f64f6
https://doi.org/10.1111/bph.13154
https://doi.org/10.1111/bph.13154
Autor:
Annamária Marton, Zoltán Hegedűs, Lóránt Lakatos, Gabriella F. Kocsis, Csaba Vizler, Lajos Kemény, Vilmos Tubak, Máté Manczinger, István Nagy, Lilla Ördögh, Alexandra Bocsik, Eva Kondorosi, Andrea Vörös, Mária A. Deli
Publikováno v:
BioMed Research International, Vol 2015 (2015)
BioMed Research International
BioMed Research International
To better understand the molecular events underlying vulvovaginal candidiasis, we established anin vitrosystem. Immortalized vaginal epithelial cells were infected with live, yeast formC. albicansandC. albicanscultured in the same medium without vagi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74ab1ff0c3869e955ea97faca086825e
https://doi.org/10.1155/2015/398045
https://doi.org/10.1155/2015/398045
Autor:
Gabriella F. Kocsis, Márton Pipicz, Zoltán Varga, Tamás Csont, Péter Ferdinandy, László Sárváry-Arantes, Péter Bencsik
Publikováno v:
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules, Vol 22, Iss 3, p 433 (2017)
Molecules; Volume 22; Issue 3; Pages: 433
Molecules, Vol 22, Iss 3, p 433 (2017)
Molecules; Volume 22; Issue 3; Pages: 433
Administration of low-dose endotoxin (lipopolysaccharide, LPS) 24 h before a lethal ischemia induces pharmacological late preconditioning. The exact mechanism of this phenomenon is not clear. Here we aimed to investigate whether low-dose LPS exerts l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d93b280b54bb3c3092bd1370db0c1b99
https://pubmed.ncbi.nlm.nih.gov/28282895
https://pubmed.ncbi.nlm.nih.gov/28282895
Autor:
Szilvia Török, Gergő Szűcs, Gabriella F. Kocsis, Tamás Csont, Csaba Csonka, Péter Ferdinandy, Anikó Görbe, Zsolt Murlasits, János Pálóczi
Publikováno v:
Cardiovascular Drugs and Therapy. 27:269-277
Farnesol is a key metabolite of the mevalonate pathway and known as an antioxidant. We examined whether farnesol treatment protects the ischemic heart. Male Wistar rats were treated orally with 0.2, 1, 5, and 50 mg/kg/day farnesol/vehicle for 12 days
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::685db35c9ebdb4cc747ed0cad35cc2da
https://doi.org/10.1007/s10557-013-6460-2
https://doi.org/10.1007/s10557-013-6460-2
Autor:
Kathryn W Woodburn, Márta Sárközy, Gergő Szűcs, Anikó Görbe, Yijun Pan, Gabriella F. Kocsis, Csaba Csonka, Tamás Csont, Christopher P. Holmes, Péter Bencsik, Zsolt Murlasits, János Pálóczi, Ashok Bhandari, Péter Ferdinandy, Krisztina Kiss, Judit Pipis, Mehrdad Shamloo
Erythropoietin (EPO) has been shown to protect the heart against acute myocardial infarction in pre-clinical studies, however, EPO failed to reduce infarct size in clinical trials and showed significant safety problems. Here, we investigated cardiopr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff22347ecde074a4299cc4921f2dc022
https://hdl.handle.net/10576/4748
https://hdl.handle.net/10576/4748
Autor:
Márton Pipicz, Gabriella F. Kocsis, Péter Bencsik, János Pálóczi, Tamás Csont, Csaba Csonka, Péter Ferdinandy, Márta Sárközy, Zoltán Varga
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 303:H1229-H1236
Metabolic diseases such as hyperlipidemia and diabetes attenuate the cardioprotective effect of ischemic preconditioning. In the present study, we examined whether another metabolic disease, prolonged uremia, affects ischemia/reperfusion injury and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ac27f1bc15c04a85f0e8960bfa7498
https://doi.org/10.1152/ajpheart.00379.2012
https://doi.org/10.1152/ajpheart.00379.2012
Autor:
Péter Bencsik, Csaba Csonka, Péter Ferdinandy, Tamás Csont, Gabor Novak, Gabriella F. Kocsis, Veronika Fekete, Krisztina Kupai
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 61:163-170
Ischemic heart disease is a major cause of morbidity and mortality worldwide. Myocardial ischemia followed by reperfusion results in tissue injury termed ischemia/reperfusion injury which is characterized by decreased myocardial contractile function,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2caca51a797f10fb0aa4c30310c0f73c
https://doi.org/10.1016/j.vascn.2010.02.014
https://doi.org/10.1016/j.vascn.2010.02.014
Autor:
Zoltán Varga, László G. Puskás, Anikó Görbe, Gabriella F. Kocsis, Nóra Faragó, Thomas Thum, Renáta Gáspár, Tamás Csont, Péter Bencsik, Csaba Csonka, Ágnes Zvara, Márton Pipicz, Péter Ferdinandy
We aimed to characterize early changes in microRNA expression in acute cardioprotection by ischemic pre- and postconditioning in rat hearts. Hearts isolated from male Wistar rats were subjected to 1) time-matched nonischemic perfusion, 2) ischemia-re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::703681ad0e824586807859c06a244bae
https://aperta.ulakbim.gov.tr/record/63873
https://aperta.ulakbim.gov.tr/record/63873
Autor:
Péter Ferdinandy, Gabriella F. Kocsis, Judit Pipis, Csaba Csonka, Zoltán Varga, János Pálóczi, Tamás Csont, István Belecz, Péter Bencsik, Anikó Görbe
Publikováno v:
Pharmacological research. 80
Pharmacological inhibition of matrix metalloproteinase-2 (MMP-2) is a promising target for acute cardioprotection against ischemia/reperfusion injury. Therefore, here we investigated if the MMP inhibitor ilomastat administered either before ischemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43a3e346ee82c8c8ac69e349bb07e515
https://pubmed.ncbi.nlm.nih.gov/24380772
https://pubmed.ncbi.nlm.nih.gov/24380772